A simple T-cell test to show the full picture of body's immune response to COVID-19

by Duke-NUS Medical SchoolGraphical abstract. Credit: DOI: 10.1172/JCI152379Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases

Updated on: March 26,2024 11

A simple T-cell test to show the full picture of body's immune response to COVID-19

by Duke-NUS Medical SchoolGraphical abstract. Credit: DOI: 10.1172/JCI152379Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases

Updated on:March 26,2024 11

Republic of Congo reports its first mpox virus cases, in several regions

by Louis Patrick OkambaVials of single doses of the Jynneos vaccine for monkeypox are seen from a cooler at a vaccinations site on Aug. 29, 2022, in the Brooklyn borough of New York. The Republic of C

Updated on: March 20,2024 19

Republic of Congo reports its first mpox virus cases, in several regions

by Louis Patrick OkambaVials of single doses of the Jynneos vaccine for monkeypox are seen from a cooler at a vaccinations site on Aug. 29, 2022, in the Brooklyn borough of New York. The Republic of C

Updated on:March 20,2024 19

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the

Updated on: April 30,2024 0

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the

Updated on:April 30,2024 0

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Updated on: October 21,2024 0

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Updated on:October 21,2024 0

US mpox cases rising again as vaccinations lag

by Robin FosterMpox cases are climbing again in the United States, with the number of reported infections now twice as high as they were at this time last year, new government data shows.In response,&

Updated on: April 30,2024 0

US mpox cases rising again as vaccinations lag

by Robin FosterMpox cases are climbing again in the United States, with the number of reported infections now twice as high as they were at this time last year, new government data shows.In response,&

Updated on:April 30,2024 0

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea

Updated on: May 05,2024 18

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea

Updated on:May 05,2024 18

Why has October been so bad for a virus known as RSV?

by Harriet Blair RowanCredit: Pixabay/CC0 Public DomainOctober is usually a quiet month for Dr. Julie Kim and her colleagues at their pediatrics practice in Los Gatos, after the summer rush for physic

Updated on: June 08,2024 3

Why has October been so bad for a virus known as RSV?

by Harriet Blair RowanCredit: Pixabay/CC0 Public DomainOctober is usually a quiet month for Dr. Julie Kim and her colleagues at their pediatrics practice in Los Gatos, after the summer rush for physic

Updated on:June 08,2024 3

A new class of antibodies against COVID-19 is being put to the test

by Garvan Institute of Medical ResearchStructural characterization of the broadly neutralizing class 1 antibody GAR05. a Cryo-EM structure of GAR05 Fab bound to trimeric spike (3.27 Å resolution)

Updated on: March 25,2024 11

A new class of antibodies against COVID-19 is being put to the test

by Garvan Institute of Medical ResearchStructural characterization of the broadly neutralizing class 1 antibody GAR05. a Cryo-EM structure of GAR05 Fab bound to trimeric spike (3.27 Å resolution)

Updated on:March 25,2024 11

Clues to COVID-19 complications come from NET-like inflammatory response

by University of Utah Health SciencesUniversity of Utah Health critical care specialist Elizabeth Middleton, MD, treats patients with COVID-19 in the intensive care unit. A research team includin

Updated on: April 09,2024 19

Clues to COVID-19 complications come from NET-like inflammatory response

by University of Utah Health SciencesUniversity of Utah Health critical care specialist Elizabeth Middleton, MD, treats patients with COVID-19 in the intensive care unit. A research team includin

Updated on:April 09,2024 19

Two California dairy workers were infected with bird flu, latest human cases in US

by Jonel AlecciaIn this photo provided by the U.S. Department of Agriculture, an animal caretaker collects a blood sample from a dairy calf vaccinated against bird flu in a containment building at the

Updated on: November 14,2024 0

Two California dairy workers were infected with bird flu, latest human cases in US

by Jonel AlecciaIn this photo provided by the U.S. Department of Agriculture, an animal caretaker collects a blood sample from a dairy calf vaccinated against bird flu in a containment building at the

Updated on:November 14,2024 0

New COVID-19 strategy: Vaccinate potential superspreaders first

by Macquarie UniversityCredit: Pixabay/CC0 Public DomainWith thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the fron

Updated on: April 12,2024 11

New COVID-19 strategy: Vaccinate potential superspreaders first

by Macquarie UniversityCredit: Pixabay/CC0 Public DomainWith thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the fron

Updated on:April 12,2024 11

SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

by Public Library of ScienceCredit: Pixabay/CC0 Public DomainAll coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-base

Updated on: April 22,2024 12

SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

by Public Library of ScienceCredit: Pixabay/CC0 Public DomainAll coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-base

Updated on:April 22,2024 12